Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Plucked hairs can be used instead of skin biopsies to study hair traits because they contain specific cells related to hair.

Self-perceived facial aging is linked to skin pigmentation, immune system, hair loss in men, and genes related to the skin's structure.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

Identified genes linked to male-pattern baldness may help develop new treatments.

New insights into cell communication in psoriasis suggest innovative drug treatments.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Using old drugs for new uses can help treat rare immune deficiencies.

Eating glucoraphanin can help prevent psychosis in offspring whose mothers had immune system activation.

CD2 might be a new treatment target for patchy alopecia areata.

The conclusion suggests that early signs of hidradenitis suppurativa may start in the hair follicle, with genetic and immune factors playing a role, highlighting the need for more research on the hair follicle's immune system.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

The dog fully recovered one month after treatment.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Phospholipase A2 enzymes play key roles in skin health and disease.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

FOXN1 gene variants cause low T cells and immune issues from birth.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.